Strategy and tactics of treatment in patients with metastatic colorectal cancer
https://doi.org/10.18027/2224-5057-2015-2-78-84
Abstract
About the Authors
A. B. MoiseenkoRussian Federation
к. м.н., хирург-онколог отделения абдоминальной онкологии, St.Petersburg
ALEKSEY GULYAEV
Russian Federation
д. м.н., профессор, руководитель отделения абдоминальной онкологии, Санкт-Петербург
ALEKSEY KARACHUN
Russian Federation
д. м.н., заведующий отделением абдоминальной онкологии, Санкт-Петербург
ANNA BELYAEVA
Russian Federation
к. м.н., научный сотрудник отделения абдоминальной онкологии, Санкт-Петербург
ALEXANDER KORNILOV
Russian Federation
к. м.н., хирург-онколог отделения абдоминальной онкологии, Санкт-Петербург
References
1. Aliev V.A., Barsukov Yu.A., Nikolaev A.V. et al. Justification of providing operations for cytoruduction for metastatic colorectal cancer – a surgeon’s opinion. Malignant tumors. 2012. Vol.2. № 2 – p. 40–45.
2. Chissov V.I., Starinskiy V.V., Petrova G.V. Malignant tumors in Russia in 2007 (morbidity and mortality). Moscow. 2009. p.252.
3. Merabishvili V.M. Malignant tumors in the world, in Russia and in St.Petersburg. 2007/ – p/422.
4. Merabishvili V.M. Oncological service in St/Petersburg in 2007 (morbidity, mortality, survival). St.Petersburg. 2008. p.256.
5. Treatment of malignant tumors Oncologists And Chemotherapeutists Society guideline. 2013.
6. Patyutko Yu.I., Sagaydak I.V., Polyakov A.V. Combined treatment of patients with colorectal cancer with metastatic lesions of the liver. Russian medical journal/ 2009/ Vol.13. p.853–862.
7. Kaprin A.D., Starinskiy V.V., Petrova G.V. Current status of oncological service in Russia in 2013. Moscow. 2014. p.235.
8. Adam R., Aloia T. A. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?// J ClinOncol, 2009.– Vol. 27.– P. 1343–1345.
9. Adam R., Wicherts D. A., De Haas R. J. et al. Complete pathologic response af ter preoperative chemotherapy for colorectal liver metastases: myth or reality?// Journal of Clinical Oncology, 2008.– Vol. 26, No. 10.– P. 1635–1641.
10. AJCC Cancer Staging Handbook. Seventh Edition. – 2010. SpringerScience+Business Media LLC. – 718 p.
11. Allen P. J., Kemeny N., Jarnagin W.et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.// Journal of Gastrointestinal Surgery, 2003.– Vol. 7, No. 1. – P. 109–115.
12. Benoist S., Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.//Annals of Surgical Oncology, 2009.– Vol. 16, No. 9.– P. 2385–2390.
13. Blazer D. G. III, Kishi Y., Maru D. M.et al. Pathologic response to preoperative chemotherapy: a new outcome end point af ter resection of hepatic colorectal metastases.// Journal of Clinical Oncology, 2008.– Vol. 26, No. 33.– P. 5344–5351.
14. Cancer incidence in five continents. V ol. IX./ Ed. by M. P. Curado et al.– IARC. – 2007.– P.896.
15. Chen J., Li Q., Wang C. et al. Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis,// International Journal of Colorectal Disease, 2011.– Vol. 26, No. 2 – P. 191–199.
16. Haddad A. J., Bani Hani M., Pawlik T. M., Cunningham S. C. Colorectal Liver Metastases.// International Journal of Surgical Oncology, 2011.– Vol.2011. – P.286840.
17. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin. – 2010. – V.60 – № 5.– P.277–300.
18. Khan K., Wale A., Brown G., Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone?//World J Gastroenterol, 2014.– Vol. 20., I.35 – P. 12391–12406.
19. McCarter, M.D. and Y. Fong. Role for surgical cytoreduction in multimodality treatments for cancer // Ann. Surg. Oncol. – 2001.– Vol.8, I.1.– P.38–43.
20. National Comprehensive Cancer Network, version 1.2015.
21. Nordlinger B., Sorbye H., GlimeliusB. et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.//The Lancet, 2008.– Vol. 371, No. 9617. – P. 1007–1016.
22. Reddy S. K., Barbas A. S., Clary B. M. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?// Annals of Surgical Oncology, 2009.– Vol. 16, No. 9, pp. 2395–2410.
23. Rosen S. A. et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? // Arch. Surg. – 2000.– Vol.135 (5).– P.530–535.
24. Schindl M., Wigmore S. J., Currie E. J. et al. Prognostic scoring in colorectal cancer liver metastases: development and validation.//Archives of Surgery, 2005.– Vol. 140, No. 2.– P. 183–189.
25.
Review
For citations:
Moiseenko A.B., GULYAEV A., KARACHUN A., BELYAEVA A., KORNILOV A. Strategy and tactics of treatment in patients with metastatic colorectal cancer. Malignant tumours. 2015;(2):78-84. (In Russ.) https://doi.org/10.18027/2224-5057-2015-2-78-84